Stratview Research has launched a new report, titled Allergy Diagnostic and Treatment Market, By Allergy Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens) Diagnostic Tests (Specific IgE Testing, Patch Testing, Blood Testing, Others), Drug Class (Antihistamines, Decongestants, Corticosteroids, Leukotrienes Inhibitors, Mast Cell inhibitors, Others), End-User (Diagnostic Laboratories, Hospitals, Academic Research Institutes) and Region.
Covid-19 Impact Analysis:
Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.
According to the report, The Allergy Diagnostic and Treatment Market is expected to grow from USD 33.1 billion in 2020 to USD 45.4 billion by 2026 at a CAGR of over 5.5% during the forecast period.
Market Segments' Analysis
Based on end-users, the market has been segmented into diagnostic laboratories, hospitals, and academic research institutes. The hospitals' segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled staff.
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced allergy diagnostic solutions in the healthcare sector coupled with the presence of key market players such as Danaher Corporation (US) and Lincoln Diagnostics, LLC (US). The market in Asia-Pacific is expected to be driven by rising incidences of allergic diseases in developing countries, particularly China and India.
Key Players
The following are the key players in the Allergy Diagnostic and Treatment Market
· bioMérieux SA (France)
· Danaher Corporation (US)
· Siemens AG (Germany)
· Omega Diagnostics Group (UK)
· R-Biopharm AG (Germany)
· Lincoln Diagnostics, LLC (US)
· Thermo Fisher Scientific (US)
· HOB Biotech Group Corp., Ltd (China)
· Hycor Biomedical (US)
· Stallergenes Greer (UK).
Frequently Asked Questions –
This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:
- What is the current and future market size of Allergy Diagnostic and Treatment Market?
- How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
- What will be the short and long-term effects of the pandemic?
- How are other market factors affecting the market dynamics?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the Allergy Diagnostic and Treatment Market competition?
- What are the key emerging trends and unmet needs in the present market?
- What are the strategic growth opportunities and key success factors?
Read the full report: https://www.stratviewresearch.com/Request-Sample/2427/Allergy-Diagnostic-and-Treatment-Market.html#form
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to [email protected]. You may also connect with our market experts at +1-313-307-4176.
About Stratview Research
Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.
The worldwide allergy diagnostics and treatment market size was esteemed at USD 32.06 billion in 2018 and is expected to grow further at a solid CAGR of 6.3% over the estimated period.
Expanding frequencies of hypersensitive illnesses combined with popularity for in vitro symptomatic blood tests are projected to drive business development in the coming years.
As per the assessments distributed by the World Health Organization (WHO), around 40 million instances of breathed-in hypersensitivities were accounted for in 2012 in the U.S. also, the number is expanding contributing toward the development of this market.
Additionally, factors, like evolving ways of life, expanding levels of indoor and outside contamination, helpless dietary propensities, and fast urbanization across the globe are assessed to bring about expanded frequencies of unfavorably susceptible conditions.
This, thus, is projected to assist with enlarging the market development over the course of the following, not many years.
The presentation of innovative progressed analytic and remedial items, which offer exceptionally delicate and precise outcomes, is likewise expected to emphatically affect the market development of the worldwide allergy diagnostics and treatment market over the conjecture time frame.
